About Subhra Pharma Priavate Limited
Data last updated:
Subhra Pharma Priavate Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 19 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC206746. Its GSTIN is 27AAOCS6960J1ZM (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Manhar Hasmatrai Lilaramani and Rohini Manhar Lilaramani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Krupa Near Sainath Garden Opp Union Bank Of India Tata Colony Road Mulund(E), Mumbai, Maharashtra, India – 400081.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.98 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹23.1 Lakh (net margin 1.2%) and EBITDA of ₹79.85 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.
The company is associated with 1 brand: Subhra Pharma. As per MCA filings, the company has open charges of ₹9.33 Cr and satisfied charges of ₹2.9 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website subhrapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressKrupa Near Sainath Garden Opp Union Bank Of India Tata Colony Road Mulund(E), Mumbai, Maharashtra, India – 400081
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Subhra Pharma Priavate Limited
The main business activity of Subhra Pharma Priavate is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Subhra Pharma Priavate Limited FY 2024 filings available
Subhra Pharma Priavate Limited reported revenue of ₹19.98 Cr (up 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Subhra Pharma Priavate Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 21% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Subhra Pharma Priavate Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹79.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Subhra Pharma Priavate Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Subhra Pharma Priavate are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Subhra Pharma Priavate Limited
Subhra Pharma Priavate Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Diagnostics Private Limited | ₹20.06 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Drukst Biotech Private Limited | ₹20.04 Cr (FY 2023) | •••• | •••• | 16.0% | •••• | Lucknow, Uttar Pradesh, India |
| Medi Biotek (India) Private Limited | ₹20.02 Cr (FY 2023) | •••• | •••• | -56.0% | •••• | Chennai, Tamil Nadu, India |
| Chacha Medical Agencies Private Limited | ₹20.01 Cr (FY 2017) | •••• | •••• | 5.0% | •••• | Nashik, Maharashtra, India |
| Novelty Healthshine Private Limited | ₹20 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Subhra Pharma Priavate Limited this company | ₹19.98 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| RR Pharmaceuticals Private Limited | ₹19.98 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | New Delhi, Delhi, India |
| Arya Infraceuticals Private Limited | ₹19.95 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Indace Chem India Private Limited | ₹19.93 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Thane, Maharashtra, India |
| Raddisun Pharmachem Industries Private Limited | ₹19.93 Cr (FY 2025) | •••• | •••• | -41.0% | •••• | Mumbai, Maharashtra, India |
| Raja Tradelinks Private Limited | ₹19.9 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Subhra Pharma Priavate by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Subhra Pharma Priavate Limited
Subhra Pharma Priavate Limited is audited by L K C & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| L K C & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Subhra Pharma Priavate Limited
Subhra Pharma Priavate has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manhar Hasmatrai Lilaramani | Director | 19 Aug 2010 | 16 Years 1 Months | Current |
| Rohini Manhar Lilaramani | Director | 19 Aug 2010 | 16 Years 1 Months | Current |
Ownership and Shareholding of Subhra Pharma Priavate Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Subhra Pharma Priavate Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2024 | Hdfc Bank Limited | ₹1.2 Cr | Open |
| 28 Mar 2023 | Axis Bank Limited | ₹4.47 Cr | Open |
| 18 Jul 2020 | Others | ₹44 Lakh | Open |
| 21 May 2018 | Others | ₹22 Lakh | Open |
| 07 Nov 2017 | Others | ₹3 Cr | Open |
Total charge records: 7 View all charges
Associated Brands with Subhra Pharma Priavate Limited
Subhra Pharma Priavate operates one associated brand: Subhra Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Subhra Pharma exports pharmaceutical products including oncology and contrast media worldwide. | subhrapharma.com |
Employees and EPFO Compliance at Subhra Pharma Priavate Limited
Employment history and EPFO contributions of people linked to Subhra Pharma Priavate.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Subhra Pharma Priavate Limited
Subhra Pharma Priavate Limited has 2 board changes on record since 2010: 2 appointments. The latest: Manhar Hasmatrai Lilaramani was appointed as Director on 19 Aug 2010.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Subhra Pharma Priavate Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Subhra Pharma Priavate Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Subhra Pharma Priavate Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Subhra Pharma Priavate Limited
Subhra Pharma Priavate has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCS6960J1ZM | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Subhra Pharma Priavate Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhra Pharma Priavate Limited
Subhra Pharma Priavate is an active private limited company based in Mumbai, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 19 August 2010 (16+ years old) and is registered under CIN U24100MH2010PTC206746.
Subhra Pharma Priavate reported revenue of ₹19.98 Cr for FY 2024 (up 21% YoY).
Subhra Pharma Priavate has 2 current directors:
- Manhar Hasmatrai Lilaramani - Director
- Rohini Manhar Lilaramani - Director
Subhra Pharma Priavate reported a net profit of ₹23.1 Lakh (net margin 1.2%) and EBITDA of ₹79.85 Lakh (EBITDA margin 4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Subhra Pharma Priavate is 5% over three years and 9% over five years. In the latest year (FY 2024) revenue rose 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Subhra Pharma Priavate is 27AAOCS6960J1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Subhra Pharma Priavate is U24100MH2010PTC206746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Subhra Pharma Priavate was incorporated on 19 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Subhra Pharma Priavate by revenue are Shree Diagnostics Private Limited, Drukst Biotech Private Limited, Medi Biotek (India) Private Limited, Chacha Medical Agencies Private Limited, Novelty Healthshine Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Manhar Hasmatrai Lilaramani was appointed as Director on 19 Aug 2010. Rohini Manhar Lilaramani was appointed as Director on 19 Aug 2010.
Subhra Pharma Priavate can be reached through the website subhrapharma.com. Its registered office is in Mumbai, Maharashtra, India.